| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| rituximab | b-lymphocyte antigen cd20 | biotech | NA | drugbank , DGIDB | Microscopic Polyarteritis[MeSHID:D055953] Disease[MeSHID:D004194] Rheumatoid Arthritis[MeSHID:D001172] B-Cell Lymphomas[MeSHID:D016393] Chronic Lymphocytic Leukemia[MeSHID:D015451] Granulomatosis with polyangiitis[MeSHID:D014890] Pemphigus Vulgaris[MeSHID:D010392] Unmarried[MeSHID:D012847] Lymphoma Non-Hodgkin[MeSHID:D008228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hematologic Neoplasms[MeSHID:D019337] |
3.03 | approved | antibody,inhibitor |
| rituximab | b-lymphocyte antigen cd20 | biotech | NA | drugbank , DGIDB | Microscopic Polyarteritis[MeSHID:D055953] Disease[MeSHID:D004194] Rheumatoid Arthritis[MeSHID:D001172] B-Cell Lymphomas[MeSHID:D016393] Chronic Lymphocytic Leukemia[MeSHID:D015451] Granulomatosis with polyangiitis[MeSHID:D014890] Pemphigus Vulgaris[MeSHID:D010392] Unmarried[MeSHID:D012847] Lymphoma Non-Hodgkin[MeSHID:D008228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
3.03 | approved | antibody |
| rituximab | b-lymphocyte antigen cd20 | biotech | NA | drugbank , DGIDB | Microscopic Polyarteritis[MeSHID:D055953] Disease[MeSHID:D004194] Rheumatoid Arthritis[MeSHID:D001172] B-Cell Lymphomas[MeSHID:D016393] Chronic Lymphocytic Leukemia[MeSHID:D015451] Granulomatosis with polyangiitis[MeSHID:D014890] Pemphigus Vulgaris[MeSHID:D010392] Unmarried[MeSHID:D012847] Lymphoma Non-Hodgkin[MeSHID:D008228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hematologic Neoplasms[MeSHID:D019337] |
3.03 | approved | antibody |
| rituximab | leukocyte surface antigen leu-16 | NA | Successful target | TTD , DGIDB | Microscopic Polyarteritis[MeSHID:D055953] Disease[MeSHID:D004194] Rheumatoid Arthritis[MeSHID:D001172] B-Cell Lymphomas[MeSHID:D016393] Chronic Lymphocytic Leukemia[MeSHID:D015451] Granulomatosis with polyangiitis[MeSHID:D014890] Pemphigus Vulgaris[MeSHID:D010392] Unmarried[MeSHID:D012847] Lymphoma Non-Hodgkin[MeSHID:D008228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
3.03 | approved | unknown |
| rituximab | leukocyte surface antigen leu-16 | NA | Successful target | TTD , DGIDB | Microscopic Polyarteritis[MeSHID:D055953] Disease[MeSHID:D004194] Rheumatoid Arthritis[MeSHID:D001172] B-Cell Lymphomas[MeSHID:D016393] Chronic Lymphocytic Leukemia[MeSHID:D015451] Granulomatosis with polyangiitis[MeSHID:D014890] Pemphigus Vulgaris[MeSHID:D010392] Unmarried[MeSHID:D012847] Lymphoma Non-Hodgkin[MeSHID:D008228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hematologic Neoplasms[MeSHID:D019337] |
3.03 | approved | inhibitor |
| rituximab | leukocyte surface antigen leu-16 | NA | Successful target | TTD , DGIDB | Microscopic Polyarteritis[MeSHID:D055953] Disease[MeSHID:D004194] Rheumatoid Arthritis[MeSHID:D001172] B-Cell Lymphomas[MeSHID:D016393] Chronic Lymphocytic Leukemia[MeSHID:D015451] Granulomatosis with polyangiitis[MeSHID:D014890] Pemphigus Vulgaris[MeSHID:D010392] Unmarried[MeSHID:D012847] Lymphoma Non-Hodgkin[MeSHID:D008228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hematologic Neoplasms[MeSHID:D019337] |
3.03 | approved | antibody |
| rituximab | leukocyte surface antigen leu-16 | NA | Successful target | TTD , DGIDB | Microscopic Polyarteritis[MeSHID:D055953] Disease[MeSHID:D004194] Rheumatoid Arthritis[MeSHID:D001172] B-Cell Lymphomas[MeSHID:D016393] Chronic Lymphocytic Leukemia[MeSHID:D015451] Granulomatosis with polyangiitis[MeSHID:D014890] Pemphigus Vulgaris[MeSHID:D010392] Unmarried[MeSHID:D012847] Lymphoma Non-Hodgkin[MeSHID:D008228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
3.03 | approved | inhibitor |
| rituximab | leukocyte surface antigen leu-16 | NA | Successful target | TTD , DGIDB | Microscopic Polyarteritis[MeSHID:D055953] Disease[MeSHID:D004194] Rheumatoid Arthritis[MeSHID:D001172] B-Cell Lymphomas[MeSHID:D016393] Chronic Lymphocytic Leukemia[MeSHID:D015451] Granulomatosis with polyangiitis[MeSHID:D014890] Pemphigus Vulgaris[MeSHID:D010392] Unmarried[MeSHID:D012847] Lymphoma Non-Hodgkin[MeSHID:D008228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
3.03 | approved | antibody |
| rituximab | b-lymphocyte antigen cd20 | biotech | NA | drugbank , DGIDB | Microscopic Polyarteritis[MeSHID:D055953] Disease[MeSHID:D004194] Rheumatoid Arthritis[MeSHID:D001172] B-Cell Lymphomas[MeSHID:D016393] Chronic Lymphocytic Leukemia[MeSHID:D015451] Granulomatosis with polyangiitis[MeSHID:D014890] Pemphigus Vulgaris[MeSHID:D010392] Unmarried[MeSHID:D012847] Lymphoma Non-Hodgkin[MeSHID:D008228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
3.03 | approved | antibody,inhibitor |
| rituximab | leukocyte surface antigen leu-16 | NA | Successful target | TTD , DGIDB | Microscopic Polyarteritis[MeSHID:D055953] Disease[MeSHID:D004194] Rheumatoid Arthritis[MeSHID:D001172] B-Cell Lymphomas[MeSHID:D016393] Chronic Lymphocytic Leukemia[MeSHID:D015451] Granulomatosis with polyangiitis[MeSHID:D014890] Pemphigus Vulgaris[MeSHID:D010392] Unmarried[MeSHID:D012847] Lymphoma Non-Hodgkin[MeSHID:D008228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hematologic Neoplasms[MeSHID:D019337] |
3.03 | approved | unknown |
| click here to return to the previous page | ||||||||